Bausch Health Companies (TSE:BHC) Shares Down 1.9% – Should You Sell?

Bausch Health Companies Inc. (TSE:BHC) traded down 1.9% on Tuesday . The company traded as low as C$7.30 and last traded at C$7.33. 346,542 shares were traded during mid-day trading, a decline of 25% from the average session volume of 462,667 shares. The stock had previously closed at C$7.47.

Bausch Health Companies Price Performance

The stock’s 50 day moving average price is C$7.45 and its two-hundred day moving average price is C$8.47. The firm has a market capitalization of C$2.74 billion, a price-to-earnings ratio of -2.26, a P/E/G ratio of 0.21 and a beta of 0.63. The company has a quick ratio of 0.58, a current ratio of 1.32 and a debt-to-equity ratio of -1,009.96.

Bausch Health Companies (TSE:BHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported C$1.08 earnings per share for the quarter. The firm had revenue of C$3.51 billion for the quarter. Bausch Health Companies had a negative net margin of 13.54% and a positive return on equity of 120.43%. Analysts anticipate that Bausch Health Companies Inc. will post 5.5472637 EPS for the current fiscal year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.